Prognostic factors for uterine cancer in reproductive-aged women.

PubWeight™: 0.99‹?› | Rank: Top 15%

🔗 View Article (PMID 17329517)

Published in Obstet Gynecol on March 01, 2007

Authors

Nita Karnik Lee1, Michael K Cheung, Jacob Y Shin, Amreen Husain, Nelson N Teng, Jonathan S Berek, Daniel S Kapp, Kathryn Osann, John K Chan

Author Affiliations

1: Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco, California 94143, USA.

Articles by these authors

OCEANS: a randomized, double-blind, placebo-controlled phase III trial of chemotherapy with or without bevacizumab in patients with platinum-sensitive recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer. J Clin Oncol (2012) 6.08

Ovarian conservation at the time of hysterectomy and long-term health outcomes in the nurses' health study. Obstet Gynecol (2009) 5.59

Rethinking ovarian cancer: recommendations for improving outcomes. Nat Rev Cancer (2011) 5.28

Ovarian conservation at the time of hysterectomy for benign disease. Obstet Gynecol (2005) 4.27

Long-term mortality associated with oophorectomy compared with ovarian conservation in the nurses' health study. Obstet Gynecol (2013) 3.08

Prevalence and significance of fluoroquinolone resistant Escherichia coli in patients undergoing transrectal ultrasound guided prostate needle biopsy. J Urol (2011) 2.95

Down syndrome and Alzheimer disease: response to donepezil. Arch Neurol (2002) 2.82

A replication of the Autism Diagnostic Observation Schedule (ADOS) revised algorithms. J Am Acad Child Adolesc Psychiatry (2008) 2.82

Gene expression patterns in ovarian carcinomas. Mol Biol Cell (2003) 2.55

Robot-assisted radical prostatectomy: 5-year oncological and biochemical outcomes. J Urol (2012) 2.40

Phase II trial of trastuzumab in women with advanced or recurrent, HER2-positive endometrial carcinoma: a Gynecologic Oncology Group study. Gynecol Oncol (2009) 2.32

Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers. Gynecol Oncol (2008) 2.11

Altered innate immune functioning of dendritic cells in elderly humans: a role of phosphoinositide 3-kinase-signaling pathway. J Immunol (2007) 2.04

Therapeutic role of lymph node resection in endometrioid corpus cancer: a study of 12,333 patients. Cancer (2006) 1.92

Association of lymphadenectomy and survival in stage I ovarian cancer patients. Obstet Gynecol (2007) 1.82

Analysis of phase II studies on targeted agents and subsequent phase III trials: what are the predictors for success? J Clin Oncol (2008) 1.79

Trends in demographic and clinical characteristics in women diagnosed with corpus cancer and their potential impact on the increasing number of deaths. Am J Obstet Gynecol (2008) 1.74

Validation of two instruments to assess technical bronchoscopic skill using virtual reality simulation. Respiration (2008) 1.72

U.S. Food and Drug Administration's Guidance Regarding Morcellation of Leiomyomas: Well-Intentioned, But Is It Harmful for Women? Obstet Gynecol (2016) 1.70

Defining and measuring reproductive concerns of female cancer survivors. J Natl Cancer Inst Monogr (2005) 1.70

Mast cell density, angiogenesis, blood clotting, and prognosis in women with advanced ovarian cancer. Gynecol Oncol (2005) 1.63

Gynecologic cancer prevention in Lynch syndrome/hereditary nonpolyposis colorectal cancer families. Obstet Gynecol (2007) 1.59

An alerting system improves adherence to follow-up recommendations from colonoscopy examinations. Gastroenterology (2011) 1.57

Prognostic factors and survival in 1396 patients with uterine leiomyosarcomas: emphasis on impact of lymphadenectomy and oophorectomy. Cancer (2008) 1.57

Hypothermic nerve-sparing radical prostatectomy: rationale, feasibility, and effect on early continence. Urology (2009) 1.54

Perioperative outcomes comparing patient controlled epidural versus intravenous analgesia in gynecologic oncology surgery. Gynecol Oncol (2009) 1.53

Patterns and progress in ovarian cancer over 14 years. Obstet Gynecol (2006) 1.52

Prevalence of ST131 among fluoroquinolone-resistant Escherichia coli obtained from rectal swabs before transrectal prostate biopsy. Urology (2013) 1.49

Impact of the human papilloma vaccine on cervical cancer. J Clin Oncol (2007) 1.49

Preventing perioperative complications of robotic-assisted radical prostatectomy. Urology (2013) 1.48

To treat pelvic nodes or not: could the greater testicular scatter dose from whole pelvic fields confound results of prostate cancer trials? J Clin Oncol (2009) 1.38

Intensity-modulated radiation therapy versus conventional radiation therapy for squamous cell carcinoma of the anal canal. Cancer (2011) 1.37

In vivo optical coherence tomography for the diagnosis of oral malignancy. Lasers Surg Med (2004) 1.36

Racial disparities in surgical treatment and survival of epithelial ovarian cancer in United States. J Surg Oncol (2008) 1.36

Microvascular blood flow dynamics associated with photodynamic therapy, pulsed dye laser irradiation and combined regimens. Lasers Surg Med (2006) 1.35

Small cell carcinoma of the cervix: treatment and survival outcomes of 188 patients. Am J Obstet Gynecol (2010) 1.31

Rethinking the use of radiation and chemotherapy after radical hysterectomy: a clinical-pathologic analysis of a Gynecologic Oncology Group/Southwest Oncology Group/Radiation Therapy Oncology Group trial. Gynecol Oncol (2005) 1.31

Prognostic factors for high-risk early-stage epithelial ovarian cancer: a Gynecologic Oncology Group study. Cancer (2008) 1.30

In vivo multiphoton fluorescence imaging: a novel approach to oral malignancy. Lasers Surg Med (2004) 1.26

Management of melanomas of the female genital tract. Curr Opin Oncol (2008) 1.25

Placental site trophoblastic tumor: A study of 55 cases and review of the literature emphasizing factors of prognostic significance. Gynecol Oncol (2005) 1.24

Association between amygdala volume and anxiety level: magnetic resonance imaging (MRI) study in autistic children. J Child Neurol (2006) 1.24

Significance of comprehensive surgical staging in noninvasive papillary serous carcinoma of the endometrium. Gynecol Oncol (2003) 1.24

Characteristics of success in mentoring and research productivity - a case-control study of academic centers. Gynecol Oncol (2012) 1.23

TBX3 is overexpressed in breast cancer and represses p14 ARF by interacting with histone deacetylases. Cancer Res (2008) 1.23

Stress, immunity, and cervical cancer: biobehavioral outcomes of a randomized clinical trial [corrected]. Clin Cancer Res (2008) 1.23

Secondary cytoreductive surgery for patients with relapsed epithelial ovarian carcinoma: who benefits? Cancer (2004) 1.21

In vivo diagnosis of oral dysplasia and malignancy using optical coherence tomography: preliminary studies in 50 patients. Lasers Surg Med (2009) 1.21

Enhanced killing of primary ovarian cancer by retargeting autologous cytokine-induced killer cells with bispecific antibodies: a preclinical study. Clin Cancer Res (2006) 1.20

Prognostic factors responsible for survival in sex cord stromal tumors of the ovary--a multivariate analysis. Gynecol Oncol (2005) 1.18

Detection and diagnosis of oral cancer by light-induced fluorescence. Lasers Surg Med (2003) 1.18

Influence of the gynecologic oncologist on the survival of ovarian cancer patients. Obstet Gynecol (2007) 1.18

Brief report: early social communication behaviors in the younger siblings of children with autism. J Autism Dev Disord (2005) 1.17

Prognostic factors responsible for survival in sex cord stromal tumors of the ovary--an analysis of 376 women. Gynecol Oncol (2006) 1.16

Detection of pelvic lymph node micrometastasis in stage IA2-IB2 cervical cancer by immunohistochemical analysis. Gynecol Oncol (2004) 1.14